Author

WM Watkins

Institution: Wellcome Trust

Observed institutions: Liverpool School of Tropical Medicine, Kenya Medical Research Institute, KEMRI-Wellcome Trust Research Programme, Wellcome Trust

OpenAlex ID: A5111557655

Averting a malaria disaster

1999 · NJ White, F Nosten, et al. · The Lancet · 550

Inter‐subject variability in the metabolism of proguanil to the active metabolite cycloguanil in man.

1989 · SA Ward, WM Watkins, et al. · British Journal of Clinical Pharmacology · 54

Pharmacology and parasitology: integrating experimental methods and approaches to falciparum malaria.

1992 · PA Winstanley, WM Watkins · British Journal of Clinical Pharmacology · 15

Monitoring of drug-resistant malaria in Africa

2002 · TK Mutabingwa, WM Watkins, et al. · The Lancet · 10

Short-term in vitro culturing of P. falciparum field isolates for antifolate chemosensitivity

1998 · Moses Mosobo, Evans Amukoye, et al.

The changing in-vitro chemosensitivity pattern to antifolates in P.falciparum field isolates from Kilifi, Kenya

1998 · Moses Mosobo, WM Watkins, et al.

The in vitro targeting of plasmodial DHFR by sulfadoxine in P. falciparum field isolates from Kilifi, Kenya

1997 · Moses Mosobo, Evans Amukoye, et al.

Comparison of chloroquine, pyrimethamine and sulfadoxine, and chlorproguanil and dapsone as treatment for falciparum malaria in pregnant and non‐pregnant women, Kakamega district, Kenya

1991 · M Keuter, A Van Eijk, et al. · International Journal of Gynecology & Obstetrics

Works count: 8

Citation count: 629

H-index: 4

I10-index: 4